Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4

Clinical trial NCT01686789 · COMPLETED

Trial details

NCT number

NCT01686789

Sponsor

King Abdulaziz Medical City

Status

COMPLETED

Phase

Phase 4

Study type

INTERVENTIONAL

Start date

2011-01-01

Primary completion

2015-08-01

Enrollment

181

View on ClinicalTrials.gov